Efficacy and Safety of CMAB008 Compared with Innovator Infliximab in Patients with Moderate-to-Severe Rheumatoid Arthritis Receiving Concomitant Methotrexate: A Randomized, Double-blind, Multi-center, Phase III Non-inferiority Study.

Autor: Ye, Hua1 (AUTHOR), Liu, Shengyun2 (AUTHOR), Xu, Jian3 (AUTHOR), Chai, Kexia4 (AUTHOR), He, Dongyi5 (AUTHOR), Fang, Yongfei6 (AUTHOR), Xie, Qibing7 (AUTHOR), Liu, Huaxiang8 (AUTHOR), Liu, Ying9 (AUTHOR), Hua, Bingzhu10 (AUTHOR), Hu, Jiankang11 (AUTHOR), Zhang, Zhiyi12 (AUTHOR), Zhou, Mingxuan13 (AUTHOR), Zhao, Dongbao14 (AUTHOR), Li, Yan15 (AUTHOR), Jiang, Zhenyu16 (AUTHOR), Wang, Meimei17 (AUTHOR), Li, Jingyang18 (AUTHOR), Zhang, Zhuoli19 (AUTHOR), Li, Xiaomei20 (AUTHOR)
Zdroj: Rheumatology & Therapy. Jun2023, Vol. 10 Issue 3, p757-773. 17p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje